Abstract
Since the early 1950s, vascular reactivity using isolated vessel rings has been a useful and efficient model for physiological and pharmacological studies. This experimental model was utilized in the milestone study of Dr. Robert Furchgott to discover the endothelium-derived relaxation factor (EDRF) nitric oxide (NO), opening new avenues and scientific perspectives in the vascular pathophysiology. Moreover, the isolated vessel ring preparation had an important contribution to understand many vasoactive systems. Here, we described the isolated aorta technique and pitfalls about the use of angiotensin-(1-7) peptide in this preparation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376
Furchgott RF (1998) Nitric oxide: from basic research on isolated blood vessels to clinical relevance in diabetes. An R Acad Nac Med 115:317–331
Furchgott RF (1996) The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 276:1186–1188
Vanin AF (1999) 1998 Nobel prize winners for physiology or medicine. Biochemistry 64:98–100
Williams N (1998) NO news is good news--but only for three Americans. Science 282:610–611
Santos RA, Simoes-e-Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100:8258–8263
Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277:14838–14843
Ferreira AJ, Santos RA, Bradford CN, Mecca AP, Sumners C, Katovich MJ, Raizada MK (2010) Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 55:207–213
Ferreira AJ, Santos RA (2005) Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 38:499–507
Ferreira AJ, Murca TM, Fraga-Silva RA, Castro CH, Raizada MK, Santos RA (2012) New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis. Int J Hypertens 2012:147825
Fraga-Silva RA, Da Silva DG, Montecucco F, Mach F, Stergiopulos N, da Silva RF, Santos RA (2012) The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases. Thromb Haemost 108:1089–1096
Fraga-Silva RA, Ferreira AJ, Dos Santos RA (2013) Opportunities for targeting the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension. Curr Hypertens Rep 15:31–38
Brosnihan KB, Li P, Ferrario CM (1996) Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27:523–528
Porsti I, Bara AT, Busse R, Hecker M (1994) Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 111:652–654
Feterik K, Smith L, Katusic ZS (2000) Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery. Brain Res 873:75–82
Savergnini SQ, Beiman M, Lautner RQ, de Paula-Carvalho V, Allahdadi K, Pessoa DC, Costa-Fraga FP, Fraga-Silva RA, Cojocaru G, Cohen Y, Bader M, de Almeida AP, Rotman G, Santos RA (2010) Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor. Hypertension 56:112–120
Fernandes L, Fortes ZB, Nigro D, Tostes RC, Santos RA, Catelli De Carvalho MH (2001) Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertension 37:703–709
Santos RA, Campagnole-Santos MJ, Baracho NC, Fontes MA, Silva LC, Neves LA, Oliveira DR, Caligiorne SM, Rodrigues AR, Gropen Junior C et al (1994) Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull 35:293–298
Santos RA, Haibara AS, Campagnole-Santos MJ, Simoes e Silva AC, Paula RD, Pinheiro SV, Leite MF, Lemos VS, Silva DM, Guerra MT, Khosla MC (2003) Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7). Hypertension 41:737–743
Silva DM, Vianna HR, Cortes SF, Campagnole-Santos MJ, Santos RA, Lemos VS (2007) Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides 28:702–707
Santos RA, Paula RD, Bader M, Alenina N, Ferreira AJ, Raizada MK, Costa-Fraga FC (2008) Mas-independent vasorelaxant actions of ala1-angiotensin-(1–7), a novel ACE2 product. Hypertension 52:34–131
Acknowledgment
This work was supported by the National Institute of Science and Technology in Nanobiopharmaceutics, Brazil.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Lautner, R.Q., Fraga-Silva, R.A., Ferreira, A.J., Santos, R.A.S. (2017). Vascular Reactivity of Isolated Aorta to Study the Angiotensin-(1-7) Actions. In: Touyz, R., Schiffrin, E. (eds) Hypertension. Methods in Molecular Biology, vol 1527. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6625-7_29
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6625-7_29
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6623-3
Online ISBN: 978-1-4939-6625-7
eBook Packages: Springer Protocols